AJP - Endo Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 285: E98-E105, 2003. First published March 4, 2003; doi:10.1152/ajpendo.00013.2003
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/E98    most recent
00013.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henriksen, E. J.
Right arrow Articles by Hasselwander, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henriksen, E. J.
Right arrow Articles by Hasselwander, O.

Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat

Erik J. Henriksen,1 Mary K. Teachey,1 Zachary C. Taylor,1 Stephan Jacob,2 Arne Ptock,3 Klaus Krämer,3 and Oliver Hasselwander3

1Muscle Metabolism Laboratory, Department of Physiology, University of Arizona, Tucson, Arizona 85721-0093; 2Albert-Schweitzer-Klinik, 78126 Königsfeld; and 3BASF, 67056 Ludwigshafen, Germany

Submitted 7 January 2003 ; accepted in final form 26 February 2003

The fatty acid-conjugated linoleic acid (CLA) enhances glucose tolerance and insulin action on skeletal muscle glucose transport in rodent models of insulin resistance. However, no study has directly compared the metabolic effects of the two primary CLA isomers, cis-9,trans-11-CLA (c9,t11-CLA) and trans-10,cis-12-CLA (t10,c12-CLA). Therefore, we assessed the effects of a 50:50 mixture of these two CLA isomers (M-CLA) and of preparations enriched in either c9,t11-CLA (76% enriched) or t10,c12-CLA (90% enriched) on glucose tolerance and insulin-stimulated glucose transport in skeletal muscle of the insulin-resistant obese Zucker (fa/fa) rat. Animals were treated daily by gavage with either vehicle (corn oil), M-CLA, c9,t11-CLA, or t10,c12-CLA (all CLA treatments at 1.5 g total CLA/kg body wt) for 21 consecutive days. During an oral glucose tolerance test, glucose responses were reduced (P < 0.05) by 10 and 16%, respectively, in the M-CLA and t10,c12-CLA animals, respectively, whereas insulin responses were diminished by 21 and 19% in these same groups. There were no significant alterations in these responses in the c9,t11-CLA group. Insulin-mediated glucose transport activity was enhanced by M-CLA treatment in both type I soleus (32%) and type IIb epitrochlearis (58%) muscles and by 36 and 48%, respectively, with t10,c12-CLA. In the soleus, these increases were associated with decreases in protein carbonyls (index of oxidative stress, r = -0.616, P = 0.0038) and intramuscular triglycerides (r = -0.631, P = 0.0028). Treatment with c9,t11-CLA was without effect on these variables. These results suggest that the ability of CLA treatment to improve glucose tolerance and insulin-stimulated glucose transport activity in insulin-resistant skeletal muscle of the obese Zucker rat are associated with a reduction in oxidative stress and muscle lipid levels and can be specifically ascribed to the actions of the t10,c12 isomer. In the obese Zucker rat, the c9,t11 isomer of CLA is metabolically neutral.

insulin resistance; conjugated fatty acids; epitrochlearis; soleus; lipids



Address for reprint requests and other correspondence: E. J. Henriksen, Dept. of Physiology, Ina E. Gittings Bldg. no. 93, Univ. of Arizona, Tucson, AZ 85721-0093 (E-mail: ejhenrik{at}u.arizona.edu).




This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
C. S. Stump, M. T. Hamilton, and J. R. Sowers
Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus
Mayo Clin. Proc., June 1, 2006; 81(6): 796 - 806.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. M. Larsen, S. Toubro, O. Gudmundsen, and A. Astrup
Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain
Am. J. Clinical Nutrition, March 1, 2006; 83(3): 606 - 612.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. P. O'Keefe, F. R. Perez, J. A. Sloniger, M. E. Tischler, and E. J. Henriksen
Enhanced insulin action on glucose transport and insulin signaling in 7-day unweighted rat soleus muscle
J Appl Physiol, July 1, 2004; 97(1): 63 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. M. Larsen, S. Toubro, and A. Astrup
Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies
J. Lipid Res., December 1, 2003; 44(12): 2234 - 2241.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.